CLAVULANIC ACID DERIVATIVES
Clavulanic acid derivs. of formula (I) and their salts are new: In (I) R is a monoacylamino or dicarboximido gp; R1 is opt. esterified COOH). Cpds. (I) are (i) beta-lactamase inhibitors useful for protecting penicillin- and cephalosporin-type antibiotics from attack by beta-lactamasses produced by G...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
03.09.1981
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Clavulanic acid derivs. of formula (I) and their salts are new: In (I) R is a monoacylamino or dicarboximido gp; R1 is opt. esterified COOH). Cpds. (I) are (i) beta-lactamase inhibitors useful for protecting penicillin- and cephalosporin-type antibiotics from attack by beta-lactamasses produced by Gram-positive and negative bacteria, and (ii) antibiotics active against Gram-positive and -negative bacteria, including lactamase-producing strains. A typical cpd. is Na (3R, 5R, Z)-2-(2-acetamidoethylidene)-clavam-3-carboxylate. In an example, this is prepd. from (3R, 5R, Z)-2-(2-amino-ethylidene)-clavam-3-carboxylic acid and acetic anhydride. |
---|---|
AbstractList | Clavulanic acid derivs. of formula (I) and their salts are new: In (I) R is a monoacylamino or dicarboximido gp; R1 is opt. esterified COOH). Cpds. (I) are (i) beta-lactamase inhibitors useful for protecting penicillin- and cephalosporin-type antibiotics from attack by beta-lactamasses produced by Gram-positive and negative bacteria, and (ii) antibiotics active against Gram-positive and -negative bacteria, including lactamase-producing strains. A typical cpd. is Na (3R, 5R, Z)-2-(2-acetamidoethylidene)-clavam-3-carboxylate. In an example, this is prepd. from (3R, 5R, Z)-2-(2-amino-ethylidene)-clavam-3-carboxylic acid and acetic anhydride. |
Author | A.P. TONGE C.E. NEWALL P.C. CHERRY |
Author_xml | – fullname: A.P. TONGE – fullname: C.E. NEWALL – fullname: P.C. CHERRY |
BookMark | eNrjYmDJy89L5WSQdvZxDAv1cfTzdFZwdPZ0UXBxDfIMcwzxDHMN5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8Y6hpobmlkYGTk5GxkQoAQDiAiH7 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU517920BB2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU517920BB23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:58:25 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU517920BB23 |
Notes | Application Number: AU19770030021 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19810903&DB=EPODOC&CC=AU&NR=517920B2 |
ParticipantIDs | epo_espacenet_AU517920BB2 |
PublicationCentury | 1900 |
PublicationDate | 19810903 |
PublicationDateYYYYMMDD | 1981-09-03 |
PublicationDate_xml | – month: 09 year: 1981 text: 19810903 day: 03 |
PublicationDecade | 1980 |
PublicationYear | 1981 |
RelatedCompanies | GLAXO LABORATORIES LTD |
RelatedCompanies_xml | – name: GLAXO LABORATORIES LTD |
Score | 2.3579297 |
Snippet | Clavulanic acid derivs. of formula (I) and their salts are new: In (I) R is a monoacylamino or dicarboximido gp; R1 is opt. esterified COOH). Cpds. (I) are (i)... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | CLAVULANIC ACID DERIVATIVES |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19810903&DB=EPODOC&locale=&CC=AU&NR=517920B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-KcSg_SW3Fr1q9DkTZpWWXrhrZlt5G2Ab3M4Sr--77ETr3oLbxAPvm9j-R9ANxWFV6zzUeGzIJtjAlC0UWaYXmEWxb3KlOV85ml9iQfPyytZQeed7EwKk_oh0qOiIiqEO-N4tebn0cspnwrt3flC5Je7-PMZ3r9FS7mSjdDorPQjxZzNqc6pWhJ6umjLzNRmcMQmfUeKtGOxEJUhDImZfNboMTHsL_AsdbNCXTEugeHdFd3rQcHs_a7G5st8ranMKDToMinQZpQLaAJ0xhaYEWQJUX0dAZaHGV0YuAsq-8NrYK8XU5oknPoop0vLkDjTj0WjiPM0qukmC85cWqTj4g7FKiE2X3o_znM5T99AziSJ6Mco8gVdJu3d3GNkrQpb9QhfAJRzHOK |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JT4NAFH5pqrHetGqsdeFguBFbhvVADAwQUKCNAumtYUvqpTYW49_3zUjVi94mb5JZ871l5i0At1WF16wVU4llwZYUglA0kCapJilUtTArmZfziRMtyJSHhbrowWoXC8PzhH7w5IiIqArx3nJ-vfl5xHK5b-X2rnxB0uu9n1quWH-FixnMzZCIrmN585k7oyKlaEmKyZPFMlHJEweZ9R4q2DrDgpc7LCZl81ug-EewP8ex1u0x9Jr1EAZ0V3dtCAdx992NzQ552xMY08jOs8hOQirYNHQFFy2w3E7D3Hs-BcH3UhpIOMvye0NLO-uW48jkDPpo5zfnIBR6rTS63silWTExXxZEr-ViSoxJg0qYNoLRn8Nc_NN3A4MgjaNlFCaPYzhkp8SdpMgl9Nu39-YKpWpbXvMD-QTmlnZ9 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CLAVULANIC+ACID+DERIVATIVES&rft.inventor=A.P.+TONGE&rft.inventor=C.E.+NEWALL&rft.inventor=P.C.+CHERRY&rft.date=1981-09-03&rft.externalDBID=B2&rft.externalDocID=AU517920BB2 |